Clinical Trials
35 trialsOpioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
Wake Forest University Health Sciences
Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer
Ohio State University Comprehensive Cancer Center
Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes
National Cancer Institute (NCI)
Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate
OHSU Knight Cancer Institute
Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma
M.D. Anderson Cancer Center
Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents
H. Lee Moffitt Cancer Center and Research Institute
Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC
H. Lee Moffitt Cancer Center and Research Institute
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
ARCITECT
Hoosier Cancer Research Network
Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.
Northwell Health
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer
University of Southern California
NYCRRLT
Peking Union Medical College Hospital
Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
Emory University
PCS-XI
CHU de Quebec-Universite Laval
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
NextPoint Therapeutics, Inc.
Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical
Optimal Health Research
68Ga-PSMA PET/CT in Prostate Cancer
University of Saskatchewan
DNX-2440 for Resectable Colorectal Liver Metastasis
DNAtrix, Inc.
Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.
The First Affiliated Hospital of Anhui Medical University
Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer
Sorrento Therapeutics, Inc.
LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer
Bioray Laboratories
Prostate Diffusion Imaging With Distortion Correction
Norfolk and Norwich University Hospitals NHS Foundation Trust
REPAIR
Peter MacCallum Cancer Centre, Australia
A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
PACT Pharma, Inc.
CAPTURE
Cambridge University Hospitals NHS Foundation Trust
Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate Cancer
University of Rome Tor Vergata
ClariCore System Used in Transperineal Prostate Biopsy
Precision Biopsy, Inc.
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
Roger Williams Medical Center
A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer
Enzon Pharmaceuticals, Inc.
A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies
GlaxoSmithKline
Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)
AstraZeneca
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
Envita Medical Center, Inc.
The Plenaxis® Experience Study
PRAECIS Pharmaceuticals Inc.
Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients
Gustave Roussy, Cancer Campus, Grand Paris
Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2
MetaPhore Pharmaceuticals